Wearable device

DEVICE15 trials

Sponsors

Sato Toshimi, Osaka Women's and Children's Hospital, Emory University, Byteflies, Pfizer

Conditions

Acute coronary syndrome Acute coronary syndromeBreast CancerCancerCardiac ArrestCardiorespiratory FitnessCervical Disc HerniationCervical Spinal StenosisChildern in a pediatric intensive care unit

Unknown Phase

Exercise is Medicine at Emory Seavey Internal Medicine Clinic

CompletedNCT03416634

Emory UniversityPhysical Activity

Start: 2018-08-20End: 2020-02-01Updated: 2020-02-19

Continuous Cardiorespiratory Monitoring in Cystic Fibrosis

CompletedNCT04489186

BytefliesCystic Fibrosis

Start: 2018-12-01End: 2019-12-31Updated: 2020-07-28

Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

CompletedNCT04736576

PfizerBreast Cancer

Start: 2021-02-24End: 2023-03-24Updated: 2024-11-22

Continuous monitoring of analgesia and sedation using wearable device with motion sensors in a pediatric intensive care unit

Active, not recruitingJPRN-UMIN000046203

Osaka Women's and Children's HospitalChildern in a pediatric intensive care unit

Start: 2021-12-01Target: 100Updated: 2026-06-29

Remote Monitoring to Prevent Frailty Progression in the Elderly

TerminatedNCT05173870

Neuromed IRCCSElderly, Frailty, Wearable Device

Start: 2023-06-01End: 2024-07-31Updated: 2026-04-13

Evaluation of Home Based Assessments on Participants With DMD

CompletedNCT05657938

Solid Biosciences Inc.Duchenne Muscular Dystrophy

Start: 2022-10-13End: 2023-04-04Updated: 2023-08-14

The Long COVID-19 Wearable Device Study

RecruitingNCT05741112

Scripps Translational Science InstituteChronic Fatigue Syndrome, Dysautonomia, Long COVID +3

Start: 2023-11-16End: 2025-12-01Target: 100500Updated: 2025-05-11

Wearable Sensors and Machine Learning for the Assessment of Biomechanical Risk in Lifting Tasks

CompletedNCT05777304

Istituti Clinici Scientifici Maugeri SpAWearable Devices

Start: 2010-10-07End: 2022-05-06Updated: 2023-12-28

Wearable Device to Increase Physical Activity Amongst Adults With Pain

RecruitingNCT05860478

University of West LondonMusculoskeletal Chronic Pain Conditions

Start: 2023-10-06End: 2024-04-30Target: 40Updated: 2024-04-29

Edge Computing Platform for Spine Health Risk Management Based on IoT Technology

CompletedNCT06092138

Xuanwu Hospital, BeijingCervical Disc Herniation, Cervical Spinal Stenosis, Neckbrace Device +1

Start: 2023-10-20End: 2025-06-30Updated: 2025-07-11

Impact of Online Support of Physical Activity Management Using a Wearable Device on Renal Function in Patients with Acute Coronary Syndrome

RecruitingJPRN-jRCT1022240014

Sato ToshimiAcute coronary syndrome Acute coronary syndrome

Start: 2024-05-08Target: 88Updated: 2026-06-29

Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation

RecruitingNCT06538155

Università Vita-Salute San RaffaeleCardiac Arrest, Out-Of-Hospital Cardiac Arrest

Start: 2025-01-27End: 2026-08-31Target: 500Updated: 2025-08-06

Tele-Rehabilitative Exercise Training Program in Nurses With Long COVID

CompletedNCT06840873

Shang-Lin ChiangCardiorespiratory Fitness, Exercise, Fatigue +5

Start: 2023-11-02End: 2024-11-01Updated: 2025-10-07

Wearable Devices for Patient Monitoring in Long QT Syndrome

RecruitingNCT06887387

Queen Mary University of LondonLong QT Syndrome

Start: 2025-04-01End: 2026-09-04Target: 80Updated: 2026-05-19

Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort

RecruitingNCT07030998

Murdoch Childrens Research InstituteCancer, Digital Health, Infection +1

Start: 2025-10-15End: 2027-12-31Target: 150Updated: 2025-11-17

Related Papers

Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26).

2025-07-18

Abstract P4-10-03: Potential risk factors for health-related quality of life (HRQoL) in palbociclib (PAL) plus endocrine therapy (ET) and ET alone patients with HR+/HER2- advanced breast cancer (ABC): exploratory analysis from 6-month longitudinal study (JBCRG-26)

Clinical Cancer Research2025-06-13

Impact of online support of physical activity management using a wearable device on renal function in patients with acute coronary syndrome: a randomized controlled trial protocol

PeerJ2025-02-262 citations

Abstract PO1-05-06: Health-related QOL and physical activity collected via wearable device in patients with HR+/HER2− advanced breast cancer in Japan treated with palbociclib+endocrine therapy (ET) or ET alone: 6-month longitudinal study (JBCRG-26)

Cancer Research2024-05-02